Search results

Each year, Lund Stem Cell Center presents one of its members with its Article of the Year Award. This year three distinguished nominees contended for the title. Among them, Marie Jönsson, representing the research group Molecular Neurogenetics, was awarded Article of the Year 2021, for their work in revealing how the activation of ancient viruses during brain development causes inflammation. In th

https://www.stemcellcenter.lu.se/article/scc-article-year-award-goes - 2025-10-01

A team of researchers from Lund University and the Lund Stem Cell Center have developed a new memory-efficient tool for single-cell genomic analysis called Scarf. Now available in Nature Communications, this innovative, bioinformatics software has the potential to help researchers navigate a growing treasure trove of data and set them on the path to answering new scientific questions related to hu

https://www.stemcellcenter.lu.se/article/introducing-scarf-memory-efficient-solution-single-cell-genomic-analysis - 2025-10-01

Researchers at Lund University and Lund Stem Cell Center in Sweden have developed a new method for studying age-related brain disorders. The researchers have focused on the neurodegenerative disorder Huntington’s disease and the results have now been published in the journal Brain. Basic medical research often faces the challenge of developing disease models that correspond to specific disease mec

https://www.stemcellcenter.lu.se/article/researchers-reprogram-human-skin-cells-aged-neurons-study-neurodegenerative-disorders - 2025-10-01

Sofia Wijk will defend her Ph.D. thesis on the 8th of September 2022, with a vision to contribute to the development of future cell-based therapies for patients with chronic lung disease. She has dedicated the last several years to better understanding the regenerative properties and processes of stem cells in our airways. In this interview, she tells us about her research, her journey in academia

https://www.stemcellcenter.lu.se/article/phd-defence-interview-sofia-wijk - 2025-10-01

A large amount of lungs donated cannot be used for transplantation. Researchers at Lund Stem Cell Center, Lund University in Sweden and Skåne University Hospital have conducted an animal study bringing hope that more donor lungs could be used in the future. The researchers have launched a pilot study to investigate whether the treatment will have the same positive effects on human beings. About 19

https://www.stemcellcenter.lu.se/article/new-treatment-could-result-more-donor-lungs - 2025-10-01

Sarah Warsi will defend her Ph.D. thesis on the 4th of October 2022. Driven by the desire to improve patient outcomes, she has dedicated the last several years to studying both in the clinic and the lab. During that time, her research efforts have centered on a better understanding of the functionality and fate of blood stem cells to contribute to developing improved clinical therapies for patient

https://www.stemcellcenter.lu.se/article/phd-defence-interview-sarah-warsi - 2025-10-01

The Royal Swedish Academy of Sciences has elected two new members of the Academy’s class for medical sciences. One of them is Malin Parmar, Professor of Cellular Neuroscience at Lund University, and Principal Investigator at Lund Stem Cell Center. Together with her research group, Malin Parmar has conducted several groundbreaking studies on stem cells that have led to the development of new treatm

https://www.stemcellcenter.lu.se/article/malin-parmar-elected-royal-swedish-academy-sciences - 2025-10-01

On 14 October 2022, Jessica Giacomoni will defend her Ph.D. thesis. With the ultimate goal to develop a possible, future alternative to cell transplantation for the treatment of neurodegenerative disorders, her research efforts have focused on the direct conversion of human glial cells into therapeutic neurons directly within the brain. Here, she tells us about future possibilities with this emerg

https://www.stemcellcenter.lu.se/article/turning-glia-neurons-inside-brain-phd-interview-jessica-giacomoni - 2025-10-01

Ouyang Yuan defends her Ph.D. thesis on 14 October 2022. As a medical student with a longstanding interest in blood malignancies, her research has focused on better understanding the development of a specific type of blood cancer, acute myeloid leukemia (AML). The hope is that these findings will help lead to a better understanding of AML and future treatments that can one day prevent, delay, or c

https://www.stemcellcenter.lu.se/article/placing-acute-myeloid-leukemia-under-microscope-phd-interview-ouyang-yuan - 2025-10-01

Skåne University Hospital, Lund University and Leiden University Medical Center will collaborate to develop research, education and care delivery in the field of ATMPs (Advanced Therapy Medicinal Products). That is the essence of a Memorandum of Understanding that was signed at the SciLifeLab near Stockholm on Wednesday 12 October, during the state visit of the Dutch Royal couple in Sweden. During

https://www.stemcellcenter.lu.se/article/international-collaboration-strengthen-development-atmps - 2025-10-01

An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from the Swedish Ethics Review Authority, and the STEM-PD team, led from Lund University in Sweden, is thereby ready to proceed with the trial. “We are excited and looking forward t

https://www.stemcellcenter.lu.se/article/swedish-medical-products-agency-grants-approval-clinical-study-new-stem-cell-based-parkinsons - 2025-10-01

B cells and the antibodies they produce play an important role in our immune system, protecting us from the microscopic enemies that make us ill. Uncovering how they form and are ‘programmed’ during development is key to better understanding the immune response to infections and vaccinations. A new study by researchers from Lund Stem Cell Center at Lund University in Sweden provides new insights i

https://www.stemcellcenter.lu.se/article/how-b-cells-are-programmed-early-life-can-impact-long-term-immune-health - 2025-10-01

Earlier this month, Simon Hultmark defended his Ph.D. thesis. In pursuit of his long-standing fascination for stem cells, his research over the last several years has focused on blood stem cells and cancer. All in an effort to contribute to the development of improved clinical therapies for patients with a type of blood cancer known as acute myeloid leukemia. In this interview, he tells us about h

https://www.stemcellcenter.lu.se/article/modeling-normal-and-malignant-hematopoiesis-vitro-phd-interview-simon-hultmark - 2025-10-01

At the end of October Laura Duran Lozano successfully defended her Ph.D. thesis. Motivated by the idea of helping patients and families impacted by cancer, and as part of the EU CanFaster Program, she has spent the past four years working to identify predisposing genes for a type of bone marrow cancer known as Multiple Myeloma. In this interview, we learn how her collaborative research efforts hav

https://www.stemcellcenter.lu.se/article/uncovering-genetic-risk-factors-multiple-myeloma-phd-interview-laura-duran-lozano - 2025-10-01

Eight researchers from Lund Stem Cell Center at Lund University have been awarded 41.4 million SEK in the latest announcements from the Swedish Research Council. This funding will support biomedical research on aging, health, disease, and bioengineering over the next several years. Stem cells are the building blocks of modern medicine and hold the key to tackling some of the most complex diseases

https://www.stemcellcenter.lu.se/article/stem-cell-research-aging-health-and-disease-gets-funding-boost-swedish-research-council - 2025-10-01

Principal Investigator Christopher Douse and the Epigenetics and Chromatin Dynamics research group join Lund Stem Cell Center, where they will explore the control and influence of ‘genomic dark matter’ in human brain development. Motivated by fundamental questions about mechanisms underpinning human disease, Christopher Douse’s research interests have gradually shifted from the natural sciences to

https://www.stemcellcenter.lu.se/article/new-research-group-led-christopher-douse-joins-lund-stem-cell-center - 2025-10-01

On 20 December, 2022 Kristijonas Zemaitis will defend his Ph.D. thesis. With the goal to improve the availability of human hematopoietic stem cells (HSCs) for the treatment of patients with blood disorders, he has spent the past several years working to better understand HSCs and how they are regulated to one day propagate these stem cells in the lab for therapeutic purposes. In this interview, we

https://www.stemcellcenter.lu.se/article/unravelling-mechanisms-blood-stem-cell-expansion-phd-interview-kristijonas-zemaitis - 2025-10-01

Earlier this fall, the Swedish Cancer Foundation (Cancerfonden) distributed 133 million SEK to 41 cancer researchers at Lund University. Nearly a quarter of this - 28 million SEK - has been awarded to 11 researchers from Lund Stem Cell Center, funding translational research which seeks to advance cancer diagnosis, treatment, and prevention. Isabella Artner, Associate Professor, is among the 11 res

https://www.stemcellcenter.lu.se/article/funding-basic-science-advance-cancer-research-cancerfonden-distributes-28-million-sek-lund-stem-cell - 2025-10-01

Researchers at Lund University and Lund Stem Cell Center have generated human mini bones in the lab which mirror the composition and function of human bone. The results published in Science Translational Medicine detail this step toward the future development of patient-tailored, personalized models of bone cancers and tumors. On average, the adult body consists of 206 bones. Housed in the center

https://www.stemcellcenter.lu.se/article/toward-personalized-approach-study-and-treatment-bone-cancers - 2025-10-01

Lund Stem Cell Center researchers from Lund University and Skåne University Hospital have uncovered a way to impair the growth and progression of glioblastoma tumor cells - the most aggressive form of brain cancer. The study, published in Molecular Cancer Therapeutics, shows it is possible to transform these cancer cells into cells that resemble normal, mature astrocytes. Nearly half of all cancer

https://www.stemcellcenter.lu.se/article/reprogramming-cancer-cells-impair-glioblastoma-growth - 2025-10-01